Related Experiment Videos
Infectious-inflammatory changes in cyclic AMP levels and in their regulation by prostaglandins in human peritoneal
Abstract:
Peritoneal macrophages of renal patients on continuous ambulatory peritoneal dialysis (CAPD) have been collected when CAPD was without complications, during an intercurrent infectious peritoneal inflammation and after recovery. Levels of cyclic AMP, release of cyclo-oxygenase metabolites, and responsiveness, in terms of cyclic AMP elevation, to either PGE2 or to DC-PGI2 (a stable analogue of PGI2) were examined. Peritoneal inflammation was associated with a sharp drop in cyclic AMP, which was restored after recovery. Production of TXA2, PGI2 and PGE2 parallelled the direction of changes in cyclic AMP levels, except, that release of PGE2 entirely failed to recover. Macrophages during the uncomplicated stage of CAPD proved more responsive to DC-PGI2 than to PGE2. During inflammation the cells displayed a marked increase in sensitivity towards PG stimulation. Improved sensitivity was more pronounced with PGE2 than with DC-PGI2 and so the original difference between responsiveness of the cells to the PGs was abolished. Several findings are compatible with the view that endogenous PGI2 governs the cyclic AMP levels in human non-inflammatory peritoneal macrophages. However, during infectious-inflammation the cells undergo changes which render a reduced production of PGI2 insufficient to explain the drop in cyclic AMP.
Insights
Peritoneal macrophages in renal patients undergoing continuous ambulatory peritoneal dialysis (CAPD) show altered cyclic AMP levels and prostaglandin production during inflammation. Recovery restores some functions, but PGE2 release remains impaired, impacting immune responses.
Area of Science:
- Immunology
- Cell Biology
- Nephrology
Background:
- Peritoneal macrophages play a crucial role in the host defense during continuous ambulatory peritoneal dialysis (CAPD).
- Understanding their function during infectious complications is vital for patient management.
- Cyclic AMP (cAMP) and prostaglandin (PG) pathways are key regulators of macrophage activity.
Purpose of the Study:
- To investigate the levels of cyclic AMP, prostaglandin production, and cellular responsiveness in peritoneal macrophages from CAPD patients.
- To compare these parameters during uncomplicated CAPD, infectious peritoneal inflammation, and after recovery.
Main Methods:
- Peritoneal macrophages were collected from CAPD patients at three different stages: uncomplicated CAPD, during infectious peritonitis, and after recovery.
- Levels of cyclic AMP were measured.
- The release of cyclo-oxygenase metabolites, including thromboxane A2 (TXA2), prostacyclin (PGI2), and prostaglandin E2 (PGE2), was quantified.
- Macrophage responsiveness to stimulation with PGE2 and a stable analogue of PGI2 (DC-PGI2) was assessed by measuring cAMP elevation.
Main Results:
- Peritoneal inflammation was associated with a significant decrease in cyclic AMP levels, which recovered post-inflammation.
- Prostaglandin production (TXA2, PGI2, PGE2) generally mirrored cAMP level changes, with the notable exception of PGE2, which failed to recover.
- Macrophages exhibited increased sensitivity to PG stimulation during inflammation, with PGE2 showing a more pronounced effect than DC-PGI2, diminishing their initial responsiveness difference.
- Endogenous PGI2 appears to regulate cAMP in non-inflammatory macrophages, but this mechanism is insufficient during infectious inflammation.
Conclusions:
- Infectious peritonitis significantly alters peritoneal macrophage function in CAPD patients, affecting cAMP levels and prostaglandin metabolism.
- While some macrophage functions recover after inflammation, impaired PGE2 production persists.
- Macrophages become hypersensitive to prostaglandins during inflammation, suggesting complex regulatory changes in immune response during CAPD-related infections.